These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35506181)

  • 1. Evaluating Factors Associated With Continuous Glucose Monitoring Utilization With the Type 1 Diabetes Exchange Registry.
    Bailey R; Donthi S; Markt S; Drummond C; Cullen J
    J Diabetes Sci Technol; 2023 Nov; 17(6):1580-1589. PubMed ID: 35506181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study.
    DeSalvo DJ; Noor N; Xie C; Corathers SD; Majidi S; McDonough RJ; Polsky S; Izquierdo R; Rioles N; Weinstock R; Obrynba K; Roberts A; Vendrame F; Sanchez J; Ebekozien O
    J Diabetes Sci Technol; 2023 Mar; 17(2):322-328. PubMed ID: 34632823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
    DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
    Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.
    Wong JC; Foster NC; Maahs DM; Raghinaru D; Bergenstal RM; Ahmann AJ; Peters AL; Bode BW; Aleppo G; Hirsch IB; Kleis L; Chase HP; DuBose SN; Miller KM; Beck RW; Adi S;
    Diabetes Care; 2014 Oct; 37(10):2702-9. PubMed ID: 25011947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
    Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
    J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing healthcare disparities and managed care considerations with continuous glucose monitoring.
    McAdam-Marx C
    Am J Manag Care; 2022 Jul; 28(4 Suppl):S76-S84. PubMed ID: 36007237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
    Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
    Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative.
    DeSalvo DJ; Lanzinger S; Noor N; Steigleder-Schweiger C; Ebekozien O; Sengbusch SV; Yayah Jones NH; Laubner K; Maahs DM; Holl RW
    Diabetes Technol Ther; 2022 Dec; 24(12):920-924. PubMed ID: 35947079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Equitable Access to Continuous Glucose Monitors for Alabama's Children with Type 1 Diabetes: A Quality Improvement Project.
    Schmitt J; Fogle K; Scott ML; Iyer P
    Diabetes Technol Ther; 2022 Jul; 24(7):481-491. PubMed ID: 35156834
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria.
    Galindo RJ; Aleppo G; Parkin CG; Baidal DA; Carlson AL; Cengiz E; Forlenza GP; Kruger DF; Levy C; McGill JB; Umpierrez GE
    J Diabetes Sci Technol; 2024 Jul; 18(4):974-987. PubMed ID: 36524477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries With Type 1 Diabetes.
    Kommareddi M; Wherry K; Vigersky RA
    J Clin Endocrinol Metab; 2023 Jun; 108(7):e388-e395. PubMed ID: 36715293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Glucose Monitoring Adherence in Medicare Beneficiaries with Insulin-Treated Diabetes.
    Puckrein GA; Hirsch IB; Parkin CG; Taylor BT; Norman GJ; Xu L; Marrero DG
    Diabetes Technol Ther; 2023 Jan; 25(1):31-38. PubMed ID: 36409474
    [No Abstract]   [Full Text] [Related]  

  • 17. Inequity in Adoption of Advanced Diabetes Technologies Among Medicare Fee-for-service Beneficiaries.
    Wherry K; Zhu C; Vigersky RA
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2177-e2185. PubMed ID: 34910144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
    Teo E; Hassan N; Tam W; Koh S
    Diabetologia; 2022 Apr; 65(4):604-619. PubMed ID: 35141761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors.
    Mathias P; Mahali LP; Agarwal S
    Diabetes Care; 2022 Oct; 45(10):2231-2237. PubMed ID: 36054022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management.
    Kong APS; Lim S; Yoo SH; Ji L; Chen L; Bao Y; Yeoh E; Chan SP; Wang CY; Mohan V; Cohen N; McGill MJ; Twigg SM
    Diabetes Res Clin Pract; 2023 Jul; 201():110718. PubMed ID: 37196707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.